This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...
GlobalData on MSN
ViCentra adds $13m in second close of Series D funding round
ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing ...
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
Irish Examiner on MSN
Stuart Lancaster: No 'magic wand' when it comes to the Connacht project
The former Leinster senior coach saw his new side concede eight tries in a game where they were under the pump for most of it but managed to put together a positive two-try half-hour in the first ...
A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMedtm 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR) ...
StockStory.org on MSN
3 Nasdaq 100 stocks worth your attention
The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A ...
Insulin patch pump maker ViCentra announced today that it closed a $13 million extension to its Series D financing round.
The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...
Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...
News headlines Dexcom has entered a new phase of innovation under CEO Jake Leach, focusing on personalized health technology. Despite a challenging year for stock performance, analysts highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results